At the time of writing, Essa Pharma Inc [EPIX] stock is trading at $0.21, up 3.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EPIX shares have gain 2.14% over the last week, with a monthly amount drifted -89.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Essa Pharma Inc [NASDAQ: EPIX] stock has seen the most recent analyst activity on November 04, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $2 from $15. Previously, Oppenheimer downgraded its rating to Perform on November 04, 2024. On November 04, 2024, downgrade downgraded it’s rating to Hold. Piper Sandler initiated its recommendation with a Overweight and recommended $50 as its price target on March 04, 2021. H.C. Wainwright reiterated a Buy rating for this stock on January 11, 2021, and upped its price target to $17. In a note dated November 02, 2020, Jefferies initiated an Buy rating and provided a target price of $17 on this stock.
For the past year, the stock price of Essa Pharma Inc fluctuated between $0.19 and $6.90. Currently, Wall Street analysts expect the stock to reach $9.5 within the next 12 months. Essa Pharma Inc [NASDAQ: EPIX] shares were valued at $0.21 at the most recent close of the market. An investor can expect a potential return of 4423.81% based on the average EPIX price forecast.
Analyzing the EPIX fundamentals
Gross Profit Margin for this corporation currently stands at 0.03% with Operating Profit Margin at -219.2%, Pretax Profit Margin comes in at -186.11%, and Net Profit Margin reading is -186.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.22 and Total Capital is -0.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Essa Pharma Inc [NASDAQ:EPIX] has a current ratio of 69.07. In addition, the Quick Ratio stands at 69.07 and the Cash Ratio stands at 53.72.
Transactions by insiders
Recent insider trading involved BVF PARTNERS L P/IL, 10% Owner, that happened on Aug 05 ’25 when 156.0 shares were sold. 10% Owner, BIOTECH GROWTH N V completed a deal on Nov 01 ’24 to sell 7.88 million shares. Meanwhile, Chief Operating Officer Virsik Peter sold 694.0 shares on Oct 07 ’24.
